close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

243.45 -1.10 (-0.45%)
Official Closing Price Updated: 7:00 PM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
99 100 Next >
News headline image
Wall Street Suffers Worst Day Since April as Trump Revives Trade War Fears ↗
U.S. markets were rattled on Friday after President Trump reignited trade tensions with China, triggering the sharpest sell-off since April. Tech and AI stocks led the decline, while gold and... 
Via Chartmill
Topics Artificial Intelligence Government World Trade
News headline image
Douglas Lane Adds $6 Million in J&J Stock Ahead of Earnings and Possible Biotech Deal ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
US Government Shutdown Rattles Global Markets, Igniting Uncertainty and Fueling Losses on October 10, 2025
The ongoing U.S. federal government shutdown, now in its tenth day as of October 10, 2025, has sent significant tremors through global financial markets. The persistent congressional deadlock over... 
Via MarketMinute
Topics Bonds Economy World Trade
Why Did Protagonist Therapeutics Stock Soar Today? ↗
Via Stocktwits
News headline image
Johnson & Johnson recommends shareholders reject “mini-tender” offer by Tutanota
From Johnson & Johnson
Via Business Wire
News headline image
Market Turmoil: S&P 500 and Nasdaq Plunge Amidst Renewed Trade Tensions and AI Scrutiny
New York, NY – October 10, 2025 – U.S. equity markets experienced a dramatic downturn today, with both the S&P 500 and Nasdaq Composite indices recording substantial losses, shattering a months-long... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Johnson & Johnson In Talks To Acquire Protagonist Therapeutics: Report ↗
Johnson & Johnson is in talks to buy Protagonist Therapeutics in a deal that could expand its immunology and cancer drug portfolio. 
Via Benzinga
News headline image
Is This Beaten-Down Dividend King a Buy? ↗
This company's short life on the stock market has been a constant challenge. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Johnson & Johnson Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts ↗
 
Via Benzinga
News headline image
Pfizer (NYSE:PFE) Marks 348th Consecutive Dividend Payment: A Pillar of Stability Amidst Transformation
New York, NY – October 9, 2025 – Pfizer Inc. (NYSE:PFE) has once again affirmed its steadfast commitment to shareholder returns, declaring a $0.43 per-share cash dividend for the fourth quarter of... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
Government Shutdown Casts a Shadow: Economic Data Halted, Federal Reserve Navigates Blind
The ongoing government shutdown has plunged financial markets into a state of heightened uncertainty, as the vital flow of economic data—the lifeblood of informed decision-making—grinds to a halt. With... 
Via MarketMinute
Topics Bonds Credit Cards Economy
News headline image
Pfizer's 348th Consecutive Dividend: A Beacon of Stability Amidst Industry Headwinds
New York, NY – October 9, 2025 – Pfizer Inc. (NYSE: PFE) has once again affirmed its steadfast commitment to shareholder returns, declaring a $0.43 per-share cash dividend for the fourth quarter of... 
Via MarketMinute
Topics Economy Intellectual Property Retirement
News headline image
Dow Jones Takes a Tumble Amidst Government Shutdown Fears and Economic Headwinds
The Dow Jones Industrial Average (DJIA) experienced a notable slide today, October 9, 2025, as a confluence of a U.S. government shutdown, mounting economic concerns, and specific corporate... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Johnson & Johnson to Participate in the UBS Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
News headline image
What Analysts Are Saying About Johnson & Johnson Stock ↗
 
Via Benzinga
News headline image
Top US Bankers Sound Alarm: Brace for Potential Stock Market Decline
In a series of recent and increasingly pointed warnings, some of America's most influential financial leaders are cautioning investors to prepare for a significant stock market downturn within the... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Investors Brace for Pullback as Short-Bias ETF Inflows Signal Growing Bearishness
A significant surge in capital flowing into short-bias Exchange-Traded Funds (ETFs) has sent a clear signal through the financial markets: investor sentiment is shifting towards caution and a potential... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Market Giants Retreat: S&P 500 and Nasdaq Pull Back from Record Highs Amidst Economic Headwinds
The relentless ascent of the U.S. stock market has hit a significant speed bump, as both the S&P 500 and Nasdaq Composite have retreated from their recent record highs. This pullback, occurring after... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
The Looming Spectre: What Could Puncture the Stock Market's AI-Driven Bubble?
As October 2025 unfolds, a palpable tension hangs over global financial markets. Despite record highs in major indices like the Nasdaq 100 (NASDAQ: NDX) and the FTSE 100 (LSE: UKX), a growing chorus of... 
Via MarketMinute
Topics Artificial Intelligence Economy Supply Chain
News headline image
Federal Reserve Navigates Rate Cuts Amidst Lingering Inflationary Shadows
The Federal Reserve has embarked on a delicate balancing act, initiating interest rate cuts in 2025 to bolster a softening labor market while grappling with persistent inflation concerns among some of... 
Via MarketMinute
Topics Derivatives Economy Stocks
News headline image
FDA Expands Johnson & Johnson Ulcerative Colitis Drug Approval To Pediatric Patients ↗
FDA approves Johnson & Johnson's Simponi for children with moderate to severe ulcerative colitis, supported by positive Phase 3 trial results. 
Via Benzinga
News headline image
These Were the 5 Worst-Performing Stocks in the S&P 500 in September 2025 -- and One's Decline Can Be Tied to President Trump ↗
One of these stocks lost about a quarter of its value in a single month. 
Via The Motley Fool
Topics Government Stocks World Trade
News headline image
Why AbbVie and Johnson & Johnson Could Outperform Pfizer ↗
Pfizer stock is moving higher after being named part of the TrumpRx platform; but two other biopharma companies may offer better long-term growth potential 
Via MarketBeat
News headline image
Worried About a Recession? 2 Stocks to Buy Now to Prepare Your Portfolio ↗
These two market leaders have increased their dividends for a combined 115 years. 
Via The Motley Fool
Topics Economy Government Supply Chain
News headline image
Congresswoman Violates STOCK Act With Late Trade Disclosures: Purchases Include Bitcoin ETF ↗
As legislation in Congress heats up to ban elected officials from buying and selling stocks, several members have violated the STOCK Act in 2025, failing to disclose their transactions in a timely... 
Via Benzinga
News headline image
Healthcare Sector Defies Broader Market Swings, Leads S&P 500 Momentum on October 7, 2025
On a day where the broader S&P 500 and Nasdaq Composite indices soared to new all-time record highs, the S&P 500 Healthcare sector presented a compelling, albeit nuanced, narrative of market leadership... 
Via MarketMinute
Topics Artificial Intelligence ETFs Intellectual Property
News headline image
Johnson & Johnson Reportedly Ordered To Pay $966M To Family Of Woman Who Died Of Rare Cancer Allegedly Associated With Its Talc ↗
According to a Reuters report, a Los Angeles Jury has ordered the company to pay $16 million in compensatory damages and $950 million in punitive damages. 
Via Stocktwits
Topics Bankruptcy Death Lawsuit
News headline image
Top S&P500 movers in Tuesday's pre-market session ↗
The US market session of Tuesday has yet to be opened, let's have a look at the top S&P500 gainers and losers in the pre-market session today. 
Via Chartmill
News headline image
1 Reason I'm Watching Intuitive Surgical Stock in 2026 ↗
The surgical robotics pioneer could cement its leading position for years to come. 
Via The Motley Fool
News headline image
U.S. Labor Market Stalls: Moody's Reports 'Essentially No Job Growth' Amidst Government Shutdown, Raising Recession Fears
Washington D.C., October 6, 2025 – The American labor market appears to have hit a significant speed bump, with Moody's Analytics reporting "essentially no job growth" for the U.S. in September 2025.... 
Via MarketMinute
Topics Artificial Intelligence Credit Cards Economy
< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today